When comparing the accuracy of FDG-PET versus CSF biomarkers in regard to their accuracy to detect AD converters, FDG-PET showed higher accuracy than CSF Aβ1–42, t-tau, and p-tau biomarkers individually. This evidence concerns the gene MAPT and Alzheimer disease.